Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1983 May;138(5):690–698.

Preventing infection in neutropenic cancer patients.

S M Beutler, N M Barth, A S Bayer
PMCID: PMC1010789  PMID: 6880186

Full text

PDF
690

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alavi J. B., Root R. K., Djerassi I., Evans A. E., Gluckman S. J., MacGregor R. R., Guerry D., Schreiber A. D., Shaw J. M., Koch P. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med. 1977 Mar 31;296(13):706–711. doi: 10.1056/NEJM197703312961302. [DOI] [PubMed] [Google Scholar]
  2. Appelbaum F. R., Trapani R. J., Graw R. G., Jr Consequences of prior alloimmunization during granulocyte transfusion. Transfusion. 1977 Sep-Oct;17(5):460–464. doi: 10.1046/j.1537-2995.1977.17578014584.x. [DOI] [PubMed] [Google Scholar]
  3. Bender J. F., Schimpff S. C., Young V. M., Fortner C. L., Brouillet M. D., Love L. J., Wiernik P. H. Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patients. Antimicrob Agents Chemother. 1979 Mar;15(3):455–460. doi: 10.1128/aac.15.3.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bodey G. P., Buckley M., Sathe Y. S., Freireich E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966 Feb;64(2):328–340. doi: 10.7326/0003-4819-64-2-328. [DOI] [PubMed] [Google Scholar]
  5. Bodey G. P., Gehan E. A., Freireich E. J., Frei E., 3rd Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia. Am J Med Sci. 1971 Sep;262(3):138–151. doi: 10.1097/00000441-197109000-00001. [DOI] [PubMed] [Google Scholar]
  6. Bodey G. P., Johnston D. Microbiological evaluation of protected environments during patient occupancy. Appl Microbiol. 1971 Nov;22(5):828–836. doi: 10.1128/am.22.5.828-836.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bodey G. P. Oral antibiotic prophylaxis in protected environment units: effect of nonabsorbable and absorbable antibiotics on the fecal flora. Antimicrob Agents Chemother. 1972 Apr;1(4):343–347. doi: 10.1128/aac.1.4.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bodey G. P. Oral antibiotic prophylaxis in protected environment units: effect of nonabsorbable and absorbable antibiotics on the fecal flora. Antimicrob Agents Chemother. 1972 Apr;1(4):343–347. doi: 10.1128/aac.1.4.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bodey G. P., Rodriguez V., Cabanillas F., Freireich E. J. Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission. Am J Med. 1979 Jan;66(1):74–81. doi: 10.1016/0002-9343(79)90485-6. [DOI] [PubMed] [Google Scholar]
  10. Bodey G. P., Rodriguez V. Infections in cancer patients on a protected environment-prophylactic antibiotic program. Am J Med. 1975 Oct;59(4):497–504. doi: 10.1016/0002-9343(75)90257-0. [DOI] [PubMed] [Google Scholar]
  11. Boggs D. R. Transfusion of neutrophils as prevention or treatment of infection in patients with neutropenia. N Engl J Med. 1974 May 9;290(19):1055–1062. doi: 10.1056/NEJM197405092901906. [DOI] [PubMed] [Google Scholar]
  12. Braude A. I., Ziegler E. J., McCutchan J. A., Douglas H. Immunization against nosocomial infection. Am J Med. 1981 Feb;70(2):463–466. doi: 10.1016/0002-9343(81)90789-0. [DOI] [PubMed] [Google Scholar]
  13. Broviac J. W., Cole J. J., Scribner B. H. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973 Apr;136(4):602–606. [PubMed] [Google Scholar]
  14. Chang H. Y., Rodriguez V., Narboni G., Bodey G. P., Luna M. A., Freireich E. J. Causes of death in adults with acute leukemia. Medicine (Baltimore) 1976 May;55(3):259–268. doi: 10.1097/00005792-197605000-00005. [DOI] [PubMed] [Google Scholar]
  15. Chillar R. K., Farbstein M., Ellington O. B., Turner M. A., Fahey J. L., Riihimaki D. U., Smith C., Fleming G. H., Zia P. K., Beutler E. Use of right atrial catheter for prolonged iv support in cancer patients. Cancer Treat Rep. 1980 Feb-Mar;64(2-3):243–246. [PubMed] [Google Scholar]
  16. Clift R. A., Sanders J. E., Thomas E. D., Williams B., Buckner C. D. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med. 1978 May 11;298(19):1052–1057. doi: 10.1056/NEJM197805112981904. [DOI] [PubMed] [Google Scholar]
  17. Curtis J. E., Hasselback R., Bergsagel D. E. Leukocyte transfusions for the prophylaxis and treatment of infections associated with granulocytopenia. Can Med Assoc J. 1977 Aug 20;117(4):341–345. [PMC free article] [PubMed] [Google Scholar]
  18. Dekker A. W., Rozenberg-Arska M., Sixma J. J., Verhoef J. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Intern Med. 1981 Nov;95(5):555–559. doi: 10.7326/0003-4819-95-5-555. [DOI] [PubMed] [Google Scholar]
  19. Dietrich M., Gaus W., Vossen J., van der Waaij D., Wendt F. Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results. Infection. 1977;5(2):107–114. doi: 10.1007/BF01642091. [DOI] [PubMed] [Google Scholar]
  20. Fortuny I. E., Bloomfield C. D., Hadlock D. C., Goldman A., Kennedy B. J., McCullough J. J. Granylocyte transfusion: a controlled study in patients with acuute nonlymphocytic leukemia. Transfusion. 1975 Nov-Dec;15(6):548–558. doi: 10.1046/j.1537-2995.1975.15676082229.x. [DOI] [PubMed] [Google Scholar]
  21. Gallagher J. G., Merigan T. C. Prolonged herpes-zoster infection associated with immunosuppressive therapy. Ann Intern Med. 1979 Dec;91(6):842–846. doi: 10.7326/0003-4819-91-6-842. [DOI] [PubMed] [Google Scholar]
  22. Guerrant R. L., Wood S. J., Krongaard L., Reid R. A., Hodge R. H. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone. Antimicrob Agents Chemother. 1981 Jan;19(1):33–38. doi: 10.1128/aac.19.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Guiot H. F., van der Meer J. W., van Furth R. Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Infect Dis. 1981 May;143(5):644–654. doi: 10.1093/infdis/143.5.644. [DOI] [PubMed] [Google Scholar]
  24. Gurwith M. J., Brunton J. L., Lank B. A., Harding G. K., Ronald A. R. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med. 1979 Feb;66(2):248–256. doi: 10.1016/0002-9343(79)90539-4. [DOI] [PubMed] [Google Scholar]
  25. Hann I. M., Prentice H. G., Corringham R., Blacklock H. A., Keaney M., Shannon M., Noone P., Gascoigne E., Fox J., Boesen E. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet. 1982 Apr 10;1(8276):826–829. doi: 10.1016/s0140-6736(82)91874-8. [DOI] [PubMed] [Google Scholar]
  26. Hargadon M. T., Young V. M., Schimpff S. C., Wade J. C., Minah G. E. Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia. Antimicrob Agents Chemother. 1981 Nov;20(5):620–624. doi: 10.1128/aac.20.5.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Herzig R. H., Herzig G. P., Graw R. G., Jr, Bull M. I., Ray K. K. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med. 1977 Mar 31;296(13):701–705. doi: 10.1056/NEJM197703312961301. [DOI] [PubMed] [Google Scholar]
  28. Higby D. J., Burnett D. Granulocyte transfusions: current status. Blood. 1980 Jan;55(1):2–8. [PubMed] [Google Scholar]
  29. Higby D. J., Yates J. W., Henderson E. S., Holland J. F. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med. 1975 Apr 10;292(15):761–766. doi: 10.1056/NEJM197504102921501. [DOI] [PubMed] [Google Scholar]
  30. Hughes W. T., Kuhn S., Chaudhary S., Feldman S., Verzosa M., Aur R. J., Pratt C., George S. L. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1977 Dec 29;297(26):1419–1426. doi: 10.1056/NEJM197712292972602. [DOI] [PubMed] [Google Scholar]
  31. Klastersky J., Debusscher L., Weerts D., Daneau D. Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains. Pathol Biol (Paris) 1974 Jan;22(1):5–12. [PubMed] [Google Scholar]
  32. Levine A. S., Schimpff S. C., Graw R. G., Jr, Young R. C. Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol. 1974 Apr;11(2):141–202. [PubMed] [Google Scholar]
  33. Levine A. S., Siegel S. E., Schreiber A. D., Hauser J., Preisler H., Goldstein I. M., Seidler F., Simon R., Perry S., Bennett J. E. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med. 1973 Mar 8;288(10):477–483. doi: 10.1056/NEJM197303082881001. [DOI] [PubMed] [Google Scholar]
  34. Lidwell O. M., Towers A. G. Unidirectional ("laminar") flow ventilation system for patient isolation. Lancet. 1972 Feb 12;1(7746):347–350. doi: 10.1016/s0140-6736(72)92842-5. [DOI] [PubMed] [Google Scholar]
  35. Lowenthal R. M., Grossman L., Goldman J. M., Storring R. A., Buskard N. A., Park D. S., Murphy B. C., Spiers A. S., Galton D. A. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet. 1975 Feb 15;1(7903):353–358. doi: 10.1016/s0140-6736(75)91276-3. [DOI] [PubMed] [Google Scholar]
  36. Lyman G. H., Williams C. C., Preston D. The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy. N Engl J Med. 1980 Jan 31;302(5):257–260. doi: 10.1056/NEJM198001313020503. [DOI] [PubMed] [Google Scholar]
  37. Lynch J., Jameson B., Gamble D. R., Kay H. E. Five-year analysis of protective isolation. Lancet. 1971 May 22;1(7708):1034–1040. doi: 10.1016/s0140-6736(71)91603-5. [DOI] [PubMed] [Google Scholar]
  38. Mannoni P., Rodet M., Vernant J. P., Brun B., Coquin-Radeau E. I., Bracq C., Rochant H., Dreyfus B. Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukaemia. Rev Fr Transfus Immunohematol. 1979 Dec;22(5):503–518. [PubMed] [Google Scholar]
  39. McCullough J., Weiblen B. J., Deinard A. R., Boen J., Fortuny I. E., Quie P. G. In vitro function and post-transfusion survival of granulocytes collected by continuous-flow centrifugation and by filtration leukapheresis. Blood. 1976 Aug;48(2):315–326. [PubMed] [Google Scholar]
  40. McCutchan J. A., Ziegler E. J., Braude A. I. Treatment of gram-negative bacteremia with antiserum to core glycolipid II. A controlled trial of antiserum in patients with bacteremia. Eur J Cancer. 1979;15 (Suppl):77–80. [PubMed] [Google Scholar]
  41. Murillo J., Schimpff S. C., Brouillet M. D. Axillary lesions in patients with acute leukemia: evaluation of a preventive program. Cancer. 1979 Apr;43(4):1493–1496. doi: 10.1002/1097-0142(197904)43:4<1493::aid-cncr2820430441>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  42. Murray B. E., Rensimer E. R., DuPont H. L. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med. 1982 Jan 21;306(3):130–135. doi: 10.1056/NEJM198201213060302. [DOI] [PubMed] [Google Scholar]
  43. Nauseef W. M., Maki D. G. A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med. 1981 Feb 19;304(8):448–453. doi: 10.1056/NEJM198102193040802. [DOI] [PubMed] [Google Scholar]
  44. Overholser C. D., Peterson D. E., Williams L. T., Schimpff S. C. Periodontal infection in patients with acute nonlymphocyte leukemia. Prevalence of acute exacerbations. Arch Intern Med. 1982 Mar;142(3):551–554. [PubMed] [Google Scholar]
  45. Penland W. Z., Jr, Perry S. Portable laminar-air-flow isolator. Lancet. 1970 Jan 24;1(7639):174–176. doi: 10.1016/s0140-6736(70)90411-3. [DOI] [PubMed] [Google Scholar]
  46. Pizzo P. A. Infectious complications in the child with cancer. III. Prevention. J Pediatr. 1981 Apr;98(4):524–530. doi: 10.1016/s0022-3476(81)80753-6. [DOI] [PubMed] [Google Scholar]
  47. Pizzo P. A., Levine A. S. The utility of protected-environment regimens for the compromised host: a critical assessment. Prog Hematol. 1977;10:311–332. [PubMed] [Google Scholar]
  48. Pizzo P. A. The value of protective isolation in preventing nosocomial infections in high risk patients. Am J Med. 1981 Mar;70(3):631–637. doi: 10.1016/0002-9343(81)90586-6. [DOI] [PubMed] [Google Scholar]
  49. Rodriguez V., Bodey G. P., Freireich E. J., McCredie K. B., Gutterman J. U., Keating M. J., Smith T. L., Gehan E. A. Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemia. Medicine (Baltimore) 1978 May;57(3):253–266. doi: 10.1097/00005792-197805000-00005. [DOI] [PubMed] [Google Scholar]
  50. Schiffer C. A., Aisner J., Daly P. A., Schimpff S. C., Wiernik P. H. Alloimmunization following prophylactic granulocyte transfusion. Blood. 1979 Oct;54(4):766–774. [PubMed] [Google Scholar]
  51. Schimpff S. C., Greene W. H., Young V. M., Fortner C. L., Cusack N., Block J. B., Wiernik P. H. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med. 1975 Mar;82(3):351–358. doi: 10.7326/0003-4819-82-3-351. [DOI] [PubMed] [Google Scholar]
  52. Schimpff S. C., Young V. M., Greene W. H., Vermeulen G. D., Moody M. R., Wiernik P. H. Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med. 1972 Nov;77(5):707–714. doi: 10.7326/0003-4819-77-5-707. [DOI] [PubMed] [Google Scholar]
  53. Schwartz J. S. Pneumococcal vaccine: clinical efficacy and effectiveness. Ann Intern Med. 1982 Feb;96(2):208–220. doi: 10.7326/0003-4819-96-2-208. [DOI] [PubMed] [Google Scholar]
  54. Sleijfer D. T., Mulder N. H., de Vries-Hospers H. G., Fidler V., Nieweg H. O., van der Waaij D., van Saene H. K. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer. 1980 Jun;16(6):859–869. doi: 10.1016/0014-2964(80)90140-1. [DOI] [PubMed] [Google Scholar]
  55. Strauss R. G., Connett J. E., Gale R. P., Bloomfield C. D., Herzig G. P., McCullough J., Maguire L. C., Winston D. J., Ho W., Stump D. C. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med. 1981 Sep 10;305(11):597–603. doi: 10.1056/NEJM198109103051101. [DOI] [PubMed] [Google Scholar]
  56. Vogler W. R., Winton E. F. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med. 1977 Oct;63(4):548–555. doi: 10.1016/0002-9343(77)90200-5. [DOI] [PubMed] [Google Scholar]
  57. Wade J. C., Newman K. A., Schimpff S. C., VanEcho D. A., Gelber R. A., Reed W. P., Wiernik P. H. Two methods for improved venous access in acute leukemia patients. JAMA. 1981 Jul 10;246(2):140–144. [PubMed] [Google Scholar]
  58. Wade J. C., Schimpff S. C., Hargadon M. T., Fortner C. L., Young V. M., Wiernik P. H. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med. 1981 Apr 30;304(18):1057–1062. doi: 10.1056/NEJM198104303041801. [DOI] [PubMed] [Google Scholar]
  59. Ward H. N. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med. 1970 Nov;73(5):689–694. doi: 10.7326/0003-4819-73-5-689. [DOI] [PubMed] [Google Scholar]
  60. Weiser B., Lange M., Fialk M. A., Singer C., Szatrowski T. H., Armstrong D. Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial. Ann Intern Med. 1981 Oct;95(4):436–438. doi: 10.7326/0003-4819-95-4-436. [DOI] [PubMed] [Google Scholar]
  61. Wilson J. M., Guiney D. G. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia. N Engl J Med. 1982 Jan 7;306(1):16–20. doi: 10.1056/NEJM198201073060105. [DOI] [PubMed] [Google Scholar]
  62. Winston D. J., Ho W. G., Gale R. P. Prophylactic granulocyte transfusions during chemotherapy of acute nonlymphocytic leukemia. Ann Intern Med. 1981 May;94(5):616–622. doi: 10.7326/0003-4819-94-5-616. [DOI] [PubMed] [Google Scholar]
  63. Winston D. J., Ho W. G., Gale R. P. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med. 1982 Oct;97(4):509–515. doi: 10.7326/0003-4819-97-4-509. [DOI] [PubMed] [Google Scholar]
  64. Winston D. J., Ho W. G., Howell C. L., Miller M. J., Mickey R., Martin W. J., Lin C. H., Gale R. P. Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med. 1980 Nov;93(5):671–675. doi: 10.7326/0003-4819-93-5-671. [DOI] [PubMed] [Google Scholar]
  65. Winston D. J., Ho W. G., Young L. S., Gale R. P. Prophylactic granulocyte transfusions during human bone marrow transplantation. Am J Med. 1980 Jun;68(6):893–897. doi: 10.1016/0002-9343(80)90223-5. [DOI] [PubMed] [Google Scholar]
  66. Wright D. G., Robichaud K. J., Pizzo P. A., Deisseroth A. B. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med. 1981 May 14;304(20):1185–1189. doi: 10.1056/NEJM198105143042001. [DOI] [PubMed] [Google Scholar]
  67. Yates J. W., Holland J. F. A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer. 1973 Dec;32(6):1490–1498. doi: 10.1002/1097-0142(197312)32:6<1490::aid-cncr2820320628>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  68. de Jongh C. A., Schimpff S. C., Wiernik P. H. Antibiotic prophylaxis in acute leukemia. Ann Intern Med. 1981 Dec;95(6):783–784. doi: 10.7326/0003-4819-95-6-783_3. [DOI] [PubMed] [Google Scholar]
  69. van der Waaij D., Berghuis-de Vries J. M. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. J Hyg (Lond) 1974 Apr;72(2):205–211. doi: 10.1017/s002217240002341x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. van der Waaij D., Berghuis J. M., Lekkerkerk J. E. Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J Hyg (Lond) 1972 Dec;70(4):605–610. doi: 10.1017/s0022172400022464. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES